Epocal Announces FDA Clearance Of Glucose Test

Epocal, Inc., a leading edge provider of point of care technology, announced that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System. Glucose measurements are used for the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell tumors.